阿里巴巴醫藥佈局: Tmall (天貓) 結合Alibaba Health Information Technology(阿里健康)

 Alibaba Group Holding Ltd Integrates Tmall Business To Health-Care Arm Alibaba, in efforts to reconcile its pharmacy business, has planned to integrate its Tmall business with its Alibaba Health By: HANNAH ISHMAEL Published: Apr 15, 2015 at 9:12 am ESTAlibaba Group Holding Ltd. (NYSE:BABA) announced that it will be integrating its online pharmacy business unit, Tmall, to Alibaba Health Information Technology Ltd., its healthcare arm listed on Hong Kong Exchange.The deal, which will be worth as much as $2.51 billion is mainly focused to revamp its presence in the healthcare sector. Under the deal, Alibaba will be transferring the 186 pharmacy businesses, which are present on its Tmall website to Alibaba Health Information Technology and will be receiving shares and convertible bonds in exchange. The shares and debt will increase Alibaba's stake in the health arm to as much as 55%, upon complete conversion of the convertible bonds upon maturity. Currently, Alibaba group holds 38% stake in the health arm.Alibaba Health announced in a filing with the Hong Kong Stock Exchange that the company has agreed to pay share and debt of worth HK$19.45 billion, and after the completion of the deal, the parent company will treat the health arm as a consolidated subsidiary.It was further announced by Alibaba health that the stocks will be issued to Alibaba Group for HK$5.28 per share, which translates to over 20% discount from the price of HK$6.68 at which the stocks traded on March 20, before the trading was halted. The convertible bonds are set at the conversion price of HK$5.808 per share.The health arm also mentioned in the filing that the price was agreed upon during negotiations with the Alibaba group by analyzing the 30-day trading before the halt, and keeping in view the fact that the parent already is in charge of controlling all of its businesses. Further the filing announced that the shares of the health arm will resume trading today, on April 15.Alibaba Group announced that the deal is expected to close by the third quarter of 2015. Moreover, the deal, under Hong Kong's rules, will be seen as a reverse takeover, according to Alibaba Health.The consolidation of the website to the health arm is a part of Alibaba Group's strategy to position itself as a leader in the medical industry as well, as the government of China is reviewing the fragmented healthcare system for revamping. Alibaba mentioned that upon the final closing of the deal, Alibaba will be able to expand into selling the prescription drugs, contingent upon approval from the regulators. The market for prescription drugs in China has reached $149 billion; however the government hasn't yet approved the drugs to be sold via Internet. Currently, Tmall is offering a wide range of healthcare related products and services including, OTC drugs, medical devices, contact lenses, facility for patients to make appointment for doctors and receive electronic copies of their diagnostic test results. Further the website also sells clothes and other household items."The group will benefit from the exclusive right to operate an online transaction platform for Online Pharmacies on Tmall's platform for the sale of products by Online Pharmacies, including products that require seller to possess an Internet Drug Transaction Service Qualification Certificates (Type C), and products that do not require any licence," the company mentioned in the statement.